Infliximab?(trade names?Remicade?among others) is a?chimeric?monoclonal antibody?biologic?drug that works against tumor necrosis factor alpha (TNF-?) and is used to treat?autoimmune?diseases.
This report aims to provide a comprehensive presentation of the global market for Remicade (infliximab) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade (infliximab) Drug. This report contains market size and forecasts of Remicade (infliximab) Drug in global, including the following market information:
Global Remicade (infliximab) Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Remicade (infliximab) Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Remicade (infliximab) Drug companies in 2022 (%)
The global Remicade (infliximab) Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brands Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Remicade (infliximab) Drug include Janssen, Hospira, Celltrion Healthcare, Epirus Biopharmaceuticals and Samsung Bioepsis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Remicade (infliximab) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remicade (infliximab) Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, by Type, 2022 (%)
Brands Drugs
Generic Drugs
Global Remicade (infliximab) Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, by Application, 2022 (%)
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other
Global Remicade (infliximab) Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remicade (infliximab) Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Remicade (infliximab) Drug revenues share in global market, 2022 (%)
Key companies Remicade (infliximab) Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Remicade (infliximab) Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Remicade (infliximab) Drug, market overview.
Chapter 2: Global Remicade (infliximab) Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Remicade (infliximab) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remicade (infliximab) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Remicade (infliximab) Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Remicade (infliximab) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Remicade (infliximab) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Remicade (infliximab) Drug Overall Market Size
2.1 Global Remicade (infliximab) Drug Market Size: 2022 VS 2029
2.2 Global Remicade (infliximab) Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Remicade (infliximab) Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Remicade (infliximab) Drug Players in Global Market
3.2 Top Global Remicade (infliximab) Drug Companies Ranked by Revenue
3.3 Global Remicade (infliximab) Drug Revenue by Companies
3.4 Global Remicade (infliximab) Drug Sales by Companies
3.5 Global Remicade (infliximab) Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Remicade (infliximab) Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Remicade (infliximab) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Remicade (infliximab) Drug Players in Global Market
3.8.1 List of Global Tier 1 Remicade (infliximab) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Remicade (infliximab) Drug Market Size Markets, 2022 & 2029
4.1.2 Brands Drugs
4.1.3 Generic Drugs
4.2 By Type - Global Remicade (infliximab) Drug Revenue & Forecasts
4.2.1 By Type - Global Remicade (infliximab) Drug Revenue, 2018-2023
4.2.2 By Type - Global Remicade (infliximab) Drug Revenue, 2024-2029
4.2.3 By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Remicade (infliximab) Drug Sales & Forecasts
4.3.1 By Type - Global Remicade (infliximab) Drug Sales, 2018-2023
4.3.2 By Type - Global Remicade (infliximab) Drug Sales, 2024-2029
4.3.3 By Type - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
4.4 By Type - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Remicade (infliximab) Drug Market Size, 2022 & 2029
5.1.2 Crohn's Disease
5.1.3 Pediatric Crohn's Disease
5.1.4 Ulcerative Colitis
5.1.5 Pediatric Ulcerative Colitis
5.1.6 Other
5.2 By Application - Global Remicade (infliximab) Drug Revenue & Forecasts
5.2.1 By Application - Global Remicade (infliximab) Drug Revenue, 2018-2023
5.2.2 By Application - Global Remicade (infliximab) Drug Revenue, 2024-2029
5.2.3 By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Remicade (infliximab) Drug Sales & Forecasts
5.3.1 By Application - Global Remicade (infliximab) Drug Sales, 2018-2023
5.3.2 By Application - Global Remicade (infliximab) Drug Sales, 2024-2029
5.3.3 By Application - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
5.4 By Application - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Remicade (infliximab) Drug Market Size, 2022 & 2029
6.2 By Region - Global Remicade (infliximab) Drug Revenue & Forecasts
6.2.1 By Region - Global Remicade (infliximab) Drug Revenue, 2018-2023
6.2.2 By Region - Global Remicade (infliximab) Drug Revenue, 2024-2029
6.2.3 By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Remicade (infliximab) Drug Sales & Forecasts
6.3.1 By Region - Global Remicade (infliximab) Drug Sales, 2018-2023
6.3.2 By Region - Global Remicade (infliximab) Drug Sales, 2024-2029
6.3.3 By Region - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Remicade (infliximab) Drug Revenue, 2018-2029
6.4.2 By Country - North America Remicade (infliximab) Drug Sales, 2018-2029
6.4.3 US Remicade (infliximab) Drug Market Size, 2018-2029
6.4.4 Canada Remicade (infliximab) Drug Market Size, 2018-2029
6.4.5 Mexico Remicade (infliximab) Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Remicade (infliximab) Drug Revenue, 2018-2029
6.5.2 By Country - Europe Remicade (infliximab) Drug Sales, 2018-2029
6.5.3 Germany Remicade (infliximab) Drug Market Size, 2018-2029
6.5.4 France Remicade (infliximab) Drug Market Size, 2018-2029
6.5.5 U.K. Remicade (infliximab) Drug Market Size, 2018-2029
6.5.6 Italy Remicade (infliximab) Drug Market Size, 2018-2029
6.5.7 Russia Remicade (infliximab) Drug Market Size, 2018-2029
6.5.8 Nordic Countries Remicade (infliximab) Drug Market Size, 2018-2029
6.5.9 Benelux Remicade (infliximab) Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Remicade (infliximab) Drug Revenue, 2018-2029
6.6.2 By Region - Asia Remicade (infliximab) Drug Sales, 2018-2029
6.6.3 China Remicade (infliximab) Drug Market Size, 2018-2029
6.6.4 Japan Remicade (infliximab) Drug Market Size, 2018-2029
6.6.5 South Korea Remicade (infliximab) Drug Market Size, 2018-2029
6.6.6 Southeast Asia Remicade (infliximab) Drug Market Size, 2018-2029
6.6.7 India Remicade (infliximab) Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Remicade (infliximab) Drug Revenue, 2018-2029
6.7.2 By Country - South America Remicade (infliximab) Drug Sales, 2018-2029
6.7.3 Brazil Remicade (infliximab) Drug Market Size, 2018-2029
6.7.4 Argentina Remicade (infliximab) Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Remicade (infliximab) Drug Sales, 2018-2029
6.8.3 Turkey Remicade (infliximab) Drug Market Size, 2018-2029
6.8.4 Israel Remicade (infliximab) Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Remicade (infliximab) Drug Market Size, 2018-2029
6.8.6 UAE Remicade (infliximab) Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Janssen
7.1.1 Janssen Company Summary
7.1.2 Janssen Business Overview
7.1.3 Janssen Remicade (infliximab) Drug Major Product Offerings
7.1.4 Janssen Remicade (infliximab) Drug Sales and Revenue in Global (2018-2023)
7.1.5 Janssen Key News & Latest Developments
7.2 Hospira
7.2.1 Hospira Company Summary
7.2.2 Hospira Business Overview
7.2.3 Hospira Remicade (infliximab) Drug Major Product Offerings
7.2.4 Hospira Remicade (infliximab) Drug Sales and Revenue in Global (2018-2023)
7.2.5 Hospira Key News & Latest Developments
7.3 Celltrion Healthcare
7.3.1 Celltrion Healthcare Company Summary
7.3.2 Celltrion Healthcare Business Overview
7.3.3 Celltrion Healthcare Remicade (infliximab) Drug Major Product Offerings
7.3.4 Celltrion Healthcare Remicade (infliximab) Drug Sales and Revenue in Global (2018-2023)
7.3.5 Celltrion Healthcare Key News & Latest Developments
7.4 Epirus Biopharmaceuticals
7.4.1 Epirus Biopharmaceuticals Company Summary
7.4.2 Epirus Biopharmaceuticals Business Overview
7.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Major Product Offerings
7.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales and Revenue in Global (2018-2023)
7.4.5 Epirus Biopharmaceuticals Key News & Latest Developments
7.5 Samsung Bioepsis
7.5.1 Samsung Bioepsis Company Summary
7.5.2 Samsung Bioepsis Business Overview
7.5.3 Samsung Bioepsis Remicade (infliximab) Drug Major Product Offerings
7.5.4 Samsung Bioepsis Remicade (infliximab) Drug Sales and Revenue in Global (2018-2023)
7.5.5 Samsung Bioepsis Key News & Latest Developments
8 Global Remicade (infliximab) Drug Production Capacity, Analysis
8.1 Global Remicade (infliximab) Drug Production Capacity, 2018-2029
8.2 Remicade (infliximab) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Remicade (infliximab) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Remicade (infliximab) Drug Supply Chain Analysis
10.1 Remicade (infliximab) Drug Industry Value Chain
10.2 Remicade (infliximab) Drug Upstream Market
10.3 Remicade (infliximab) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Remicade (infliximab) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Remicade (infliximab) Drug in Global Market
Table 2. Top Remicade (infliximab) Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Remicade (infliximab) Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Remicade (infliximab) Drug Revenue Share by Companies, 2018-2023
Table 5. Global Remicade (infliximab) Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Remicade (infliximab) Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Remicade (infliximab) Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Remicade (infliximab) Drug Product Type
Table 9. List of Global Tier 1 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2024-2029
Table 16. By Application ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2024-2029
Table 21. By Region ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2024-2029
Table 46. Janssen Company Summary
Table 47. Janssen Remicade (infliximab) Drug Product Offerings
Table 48. Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Janssen Key News & Latest Developments
Table 50. Hospira Company Summary
Table 51. Hospira Remicade (infliximab) Drug Product Offerings
Table 52. Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Hospira Key News & Latest Developments
Table 54. Celltrion Healthcare Company Summary
Table 55. Celltrion Healthcare Remicade (infliximab) Drug Product Offerings
Table 56. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Celltrion Healthcare Key News & Latest Developments
Table 58. Epirus Biopharmaceuticals Company Summary
Table 59. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Offerings
Table 60. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Epirus Biopharmaceuticals Key News & Latest Developments
Table 62. Samsung Bioepsis Company Summary
Table 63. Samsung Bioepsis Remicade (infliximab) Drug Product Offerings
Table 64. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Samsung Bioepsis Key News & Latest Developments
Table 66. Remicade (infliximab) Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Remicade (infliximab) Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Remicade (infliximab) Drug Production by Region, 2018-2023 (K Units)
Table 69. Global Remicade (infliximab) Drug Production by Region, 2024-2029 (K Units)
Table 70. Remicade (infliximab) Drug Market Opportunities & Trends in Global Market
Table 71. Remicade (infliximab) Drug Market Drivers in Global Market
Table 72. Remicade (infliximab) Drug Market Restraints in Global Market
Table 73. Remicade (infliximab) Drug Raw Materials
Table 74. Remicade (infliximab) Drug Raw Materials Suppliers in Global Market
Table 75. Typical Remicade (infliximab) Drug Downstream
Table 76. Remicade (infliximab) Drug Downstream Clients in Global Market
Table 77. Remicade (infliximab) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Remicade (infliximab) Drug Segment by Type in 2022
Figure 2. Remicade (infliximab) Drug Segment by Application in 2022
Figure 3. Global Remicade (infliximab) Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Remicade (infliximab) Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Remicade (infliximab) Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Remicade (infliximab) Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Remicade (infliximab) Drug Revenue in 2022
Figure 9. By Type - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Remicade (infliximab) Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Remicade (infliximab) Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 23. US Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 28. Germany Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 37. China Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 44. Brazil Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Remicade (infliximab) Drug Sales Market Share, 2018-2029
Figure 48. Turkey Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Remicade (infliximab) Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Remicade (infliximab) Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Remicade (infliximab) Drug by Region, 2022 VS 2029
Figure 54. Remicade (infliximab) Drug Industry Value Chain
Figure 55. Marketing Channels
